These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6229155)

  • 21. Critical examination of the case for or against fusimotor involvement in disorders of muscle tone.
    Burke D
    Adv Neurol; 1983; 39():133-50. PubMed ID: 6229156
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy.
    Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
    Pediatr Neurol; 2007 Jan; 36(1):30-9. PubMed ID: 17162194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of spasticity to knee angular velocity and motion during gait in cerebral palsy.
    Damiano DL; Laws E; Carmines DV; Abel MF
    Gait Posture; 2006 Jan; 23(1):1-8. PubMed ID: 16311188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiparetic and antispastic effects induced by tizanidine in patients with spastic paresis.
    Knutsson E; Mårtensson A; Gransberg L
    J Neurol Sci; 1982 Feb; 53(2):187-204. PubMed ID: 7035623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of reflex activity and co-contraction during assessments of spasticity of the knee flexor and knee extensor muscles in children with cerebral palsy and different functional levels.
    Pierce SR; Barbe MF; Barr AE; Shewokis PA; Lauer RT
    Phys Ther; 2008 Oct; 88(10):1124-34. PubMed ID: 18703677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Disorders of muscle tonus and their treatment with sirdalud in patients in the early recovery period of ischemic stroke].
    Gekht AB; Burd GS; Selikhova MV; Iaish F; Beliakov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(10):22-9. PubMed ID: 9819884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The usefulness of tizanidine. A one-year follow-up of the treatment of spasticity in infantile cerebral palsy].
    Vásquez-Briceño A; Arellano-Saldaña ME; León-Hernández SR; Morales-Osorio MG
    Rev Neurol; 2006 Aug 1-15; 43(3):132-6. PubMed ID: 16871477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperactive stretch reflexes, co-contraction, and muscle weakness in children with cerebral palsy.
    Poon DM; Hui-Chan CW
    Dev Med Child Neurol; 2009 Feb; 51(2):128-35. PubMed ID: 19018843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of tizanidine in the treatment of spasticity.
    Neurology; 1994 Nov; 44(11 Suppl 9):S1-80. PubMed ID: 7970005
    [No Abstract]   [Full Text] [Related]  

  • 30. [Spastic syndrome and main directions of its treatment].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(12):4-9. PubMed ID: 14763249
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical signs, neurophysiological evaluation, and medication of spasticity--review].
    Matsumoto H; Ugawa Y
    Brain Nerve; 2008 Dec; 60(12):1409-14. PubMed ID: 19110751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacological management of spasticity.
    Saulino M; Jacobs BW
    J Neurosci Nurs; 2006 Dec; 38(6):456-9. PubMed ID: 17233517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interest of peripheral anesthetic blocks as a diagnosis and prognosis tool in patients with spastic equinus foot: a clinical and electrophysiological study of the effects of block of nerve branches to the triceps surae muscle.
    Buffenoir K; Decq P; Lefaucheur JP
    Clin Neurophysiol; 2005 Jul; 116(7):1596-600. PubMed ID: 15905125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscle afferent function and its significance for motor control mechanisms during voluntary movements in cat, monkey, and man.
    Prochazka A; Hulliger M
    Adv Neurol; 1983; 39():93-132. PubMed ID: 6229164
    [No Abstract]   [Full Text] [Related]  

  • 35. Tizanidine for spasticity.
    Med Lett Drugs Ther; 1997 Jul; 39(1004):62-3. PubMed ID: 9217694
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug therapy: spasticity (first of two parts).
    Young RR; Delwaide PJ
    N Engl J Med; 1981 Jan; 304(1):28-33. PubMed ID: 6448959
    [No Abstract]   [Full Text] [Related]  

  • 37. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
    Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral baclofen increases maximal voluntary neuromuscular activation of ankle plantar flexors in children with spasticity due to cerebral palsy.
    van Doornik J; Kukke S; McGill K; Rose J; Sherman-Levine S; Sanger TD
    J Child Neurol; 2008 Jun; 23(6):635-9. PubMed ID: 18281622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Measurement of the silent period after Hoffmann's reaction as an indicator of the effect of exercise therapy on muscle spasticity in children with cerebral palsy].
    Nowotny J; Krauze M; Moskała H; Adowska E; Marek J
    Pol Tyg Lek; 1980 Nov; 35(45):1741-3. PubMed ID: 7220374
    [No Abstract]   [Full Text] [Related]  

  • 40. The efficacy of diazepam in enhancing motor function in children with spastic cerebral palsy.
    Mathew A; Mathew MC; Thomas M; Antonisamy B
    J Trop Pediatr; 2005 Apr; 51(2):109-13. PubMed ID: 15840761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.